Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 4 boards, counting each seat separately. Longest: ALX Oncology Holdings Inc., 3 years.
ALX Oncology Holdings Inc.
Director
Olema Pharmaceuticals Inc.
Director
LB Pharmaceuticals Inc
Director
Enliven Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Enliven Therapeutics Inc. | Option exercise | +13,000 | $15.47 | $201,110 |
| Oct 1, 2026 | Enliven Therapeutics Inc. | Open-market sale | −13,000 | $46.67 | $606,719 |
Questions about J. Scott Garland
What boards is J. Scott Garland on?
J. Scott Garland sits on the boards of ALX Oncology Holdings Inc., Enliven Therapeutics Inc., LB Pharmaceuticals Inc and Olema Pharmaceuticals Inc.
How long has J. Scott Garland served on boards?
Our records show at least 9 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.